Impacts of international sanctions on Iranian pharmaceutical market

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Cheraghali, Abdol Majid ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

International sanctions; Iran; Medicines

Indexed keywords

ARTICLE; DRUG INDUSTRY; DRUG MARKETING; HEALTH INSURANCE; HUMAN; INTERNATIONAL COOPERATION; IRAN; MONEY; PUBLIC HEALTH; RISK;

EID: 84881272304     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-64     Document Type: Article

References (8)

1. The impact of economic sanctions on health and well-being. Garfield R, Relief and rehabilitation network paper 1999 31 http://www.essex.ac.uk/armedcon/ story-id/The%20Impact%20of%20Econmoic%20Sanctins%20on%20Health%20abd%20Well- Being.pdf
2. European Union sanctions and their impacts on Zimbabwe 2002-2011: finding alternative means to survive. Mbanje B, Mahuku DN, Sacha J Policy Strategic Stud 2011 1 1 12
3. The impact of sanctions and the blockade on the human right to water and sanitation in Gaza. Politics H t, Centre on Housing Rights and Evictions position paper, Switzerland 2008 http://reliefweb.int/sites/reliefweb.int/files/ resources/725D407063CED0D6C12573D9004FD791-Full-Report.pdf
4. The impact of economic sanctions on health and human rights in Haiti, 1991-1994. Gibbons E, Garfield R, Am J Public Health 1999 89 1499 1504 10.2105/AJPH.89.10.1499 10511830 (Pubitemid 29457902)
5. Trend analysis of the pharmaceutical market in Iran; 1997-2010; policy implications for developing countries. Kebriaeezadeh A, Koopaei NN, Abdollahiasl A, Nikfar S, Mohamadi N, DARU J Pharm Sci 2013 21 52 10.1186/2008-2231-21-52
6. Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry. Cheraghali AM, DARU J Pharm Sci 2012 20 35 10.1186/2008-2231-20-35
7. Economical impact of plasma fractionation project in Iran on affordability of plasma derived medicines. Cheraghali AM, Aboofazeli R, Transfusion Med 2009 19 363 368 10.1111/j.1365-3148.2009.00961.x
8. Cost effectiveness of Iran national plasma contract fractionation program. Cheraghali AM, DARU J Pharm Sci 2012 20 63 10.1186/2008-2231-20-63